Resource Center
In this podcast, Dr. Steve Kleiboeker discusses Graft Versus Host Disease (GVHD) and highlights Eurofins Viracor's suite of diagnostic tests for acute GVHD (aGVHD). The tests include the aGVHD Pre-Symptomatic Algorithm, aGVHD Symptomatic Algorithm, and aGVHD Post-Treatment Algorithm, which provide valuable tools for early detection, diagnosis, and monitoring of GVHD in transplant patients. Dr. Kleiboeker also explores this published white paper, offering insights into advancing care through these diagnostic solutions.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.